Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
70,821.89
(
-3.09%
)
News Focus
News Focus
Post# of 11559
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

StocksDiva

Send PM Follow Ignore
Followers 377
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

StocksDiva

Re: None

Thursday, 04/05/2012 7:52:24 AM

Thursday, April 05, 2012 7:52:24 AM

Post# of 11559
REGN Regeneron Pharms and Sanofi (SNY) receives Priority Review of the Biologics License Application for the investigational agent ZALTRAP from the FDA (REGN) 6.22 :

***All my posts are purely my opinion. Please do your own DD & never invest in a stock you can not afford to lose money on.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today